ORAL ZINC SULFATE IN THE TREATMENT OF ACUTE CUTANEOUS LEISHMANIASIS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

YAZDANPANAH MOHAMMAD JAVAD; MOSTOUFI S.K.; SOLEYMANI M.

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Dermatology Year:2003 | Volume:6 | Issue:2 Page(s): 20-24

Download Full-Text

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

View:

792

Download:

Cites:

Information Journal Paper

Title

ORAL ZINC SULFATE IN THE TREATMENT OF ACUTE CUTANEOUS LEISHMANIASIS

Author(s)

YAZDANPANAH MOHAMMAD JAVAD | MOSTOUFI S.K. | SOLEYMANI M. | Issue Writer Certificate

Keywords

CUTANEOUS LEISHMANIASISQ4

ORAL ZINC SULFATEQ4

TREATMENTQ3

Abstract

Background: Different local and systemic modalities are suggested in the TREATMENT of cutaneous leishmaniasis (CL), but the pentavalent antimony compounds are still considered as the first line of TREATMENT. Regarding to increase in clinical drug resistance, adverse and low effects compliance of patients, efforts for finding a more effective and safer drug continue. Objectives: To evaluate the efficacy of ORAL ZINC SULFATE in the TREATMENT of acute dry CL. Patients Methods: 31 patients with & clinical diagnosis of acute, dry CL and positive direct smear for leishman bodies were included in the trial. Patients were treated with 10 mg/kg/day ORAL ZINC SULFATE for 45 days and evaluated every 3 weeks during the period of TREATMENT and also 1.5 months after cessation of it. Results: 22 patients completed the course of TREATMENT.At the end of 45 days of TREATMENT, only two cases (9%) were cured and the remaining did not show satisfactory response. Conclusion: ORAL ZINC SULFATE has limited therapeutic value in the TREATMENT of dry CL.

Cites

A COMPARISON BETWEEN THE EFFICACY OF INTRALESIONAL INJECTION OF 2% ZINC SULFATE SOLUTION WITH GLUCANTIME IN THE TREATMENT OF ACUTE OLD WORLD CUTANEOUS LEISHMANIASIS: A RANDOMIZED, DOUBLEBLIND, CONTROLLED CLINICAL TRIAL

References

Cite

APA: Copy

YAZDANPANAH, MOHAMMAD JAVAD, MOSTOUFI, S.K., & SOLEYMANI, M.. (2003). ORAL ZINC SULFATE IN THE TREATMENT OF ACUTE CUTANEOUS LEISHMANIASIS. IRANIAN JOURNAL OF DERMATOLOGY, 6(2), 20-24. SID. https://sid.ir/paper/57678/en

Vancouver: Copy

YAZDANPANAH MOHAMMAD JAVAD, MOSTOUFI S.K., SOLEYMANI M.. ORAL ZINC SULFATE IN THE TREATMENT OF ACUTE CUTANEOUS LEISHMANIASIS. IRANIAN JOURNAL OF DERMATOLOGY[Internet]. 2003;6(2):20-24. Available from: https://sid.ir/paper/57678/en

IEEE: Copy

MOHAMMAD JAVAD YAZDANPANAH, S.K. MOSTOUFI, and M. SOLEYMANI, “ORAL ZINC SULFATE IN THE TREATMENT OF ACUTE CUTANEOUS LEISHMANIASIS,” IRANIAN JOURNAL OF DERMATOLOGY, vol. 6, no. 2, pp. 20–24, 2003, [Online]. Available: https://sid.ir/paper/57678/en

Related Journal Papers